CLINICAL STAGE IV GASTRIC CANCER AJCC V8

This early-phase trial is testing a combination of two drugs, pembrolizumab and lenvatinib, in about 15 people with advanced stomach or gastroesophageal cancer that has spread or can't be removed by surgery. Pembrolizumab helps the immune system attack cancer cells, while lenvati…

This early-phase study is testing whether adding a drug called azenosertib to the existing cancer drug trastuzumab deruxtecan (T-DXd) is safe and effective for people with HER2-positive stomach, esophageal, or other solid tumors that have spread or can't be removed by surgery. Ab…

This early-stage study tests a procedure called PIPAC that turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to th…

This study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system attack cancer more effectively. …

This study tests whether a simple, non-invasive technique called auricular acupressure (using small pellets on the ear) can improve appetite and prevent weight loss in people with advanced stomach, esophageal, or pancreatic cancer. Researchers will enroll 66 patients to see if th…

This study uses a special microscope to look at blood vessels inside solid tumors while patients are having surgery. The goal is to understand how these vessels work, which could help doctors decide if a patient's tumor is likely to respond to certain treatments. About 85 adults …